| Code: MTA11870 | Publication Date: Apr 2026 |
The South Korea Allopurinol Market is influenced by a combination of local pharmaceutical companies, each making a considerable impact on the growth of this market through their robust R&D, manufacturing strengths, and focus on affordable generics. Major players that hold a considerable share of this market include Yuhan Corporation, Hanmi Pharmaceutical Co., Ltd., and Chong Kun Dang (CKD) Pharmaceutical.
For detailed forecasts, data tables, and competitive benchmarking,
Explore the full South Korea Allopurinol Market.
According to 6Wresearch, the market for Allopurinol in South Korea is expected to grow, driven by an increase in the incidence of gout and hyperuricemia, as well as an increase in the awareness of the benefits of allopurinol as a treatment. Allopurinol, a treatment for high levels of uric acid, is a major treatment for gout and kidney stones.
The market is driven by the growing elderly population, improved accessibility of healthcare, and the growing awareness of chronic diseases, which include gout. Furthermore, the increase in healthcare expenditure, as well as the government’s support for the drug industry, is expected to be beneficial for the market’s growth.
The competitive landscape of the South Korea Allopurinol industry is dominated by drug manufacturers with a strong market presence, as well as South Korean companies that offer cost-effective products. The market players have managed to establish themselves in the market with the help of partnerships, quality products, and R&D for new forms of allopurinol. These companies also aim to capture the increasing demand for cost-effective treatment options in South Korea.
Below is a list of leading players operating in the South Korea Allopurinol Market:
| Company Name | Samjin Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1968 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Samjin Pharmaceutical is a prominent Korean drug manufacturer that provides high-quality Allopurinol formulations.
| Company Name | Hanmi Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1973 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Hanmi Pharmaceutical produces a variety of essential medicines, including treatments for hyperuricemia, utilizing advanced production facilities.
| Company Name | JW Pharmaceutical |
|---|---|
| Established Year | 1945 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
JW Pharmaceutical specializes in the development of ethical drugs and has a strong presence in the gout treatment market.
| Company Name | Yuhan Corporation |
|---|---|
| Established Year | 1926 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Yuhan Corporation is one of the most respected pharmaceutical firms, offering a wide range of prescription medicines including antigout agents.
| Company Name | Daewoong Pharmaceutical Co., Ltd. |
|---|---|
| Established Year | 1945 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Daewoong Pharmaceutical is a global healthcare group that manufactures and distributes Allopurinol while focusing on innovative drug delivery systems.
| Company Name | Boryung Pharmaceutical |
|---|---|
| Established Year | 1963 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Boryung focuses on various therapeutic areas, including cardiovascular and metabolic health, providing reliable Allopurinol tablets to the market.
| Company Name | Huons Co., Ltd. |
|---|---|
| Established Year | 1965 |
| Headquarters | Seongnam, South Korea |
| Official Website | Click Here |
Huons is a diversified healthcare company that produces finished pharmaceutical products, including essential treatments for managing uric acid levels.
| Company Name | Chong Kun Dang (CKD) Pharm |
|---|---|
| Established Year | 1941 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
CKD Pharm is a leader in the pharmaceutical industry, known for its strong manufacturing capabilities in synthetic drugs and metabolic disease treatments.
| Company Name | Dong-A ST Co., Ltd. |
|---|---|
| Established Year | 1932 |
| Headquarters | Seoul, South Korea |
| Official Website | Click Here |
Dong-A ST focuses on ethical drugs and has built a significant market presence by providing essential medications like Allopurinol to hospitals and clinics.
| Company Name | GC Biopharma |
|---|---|
| Established Year | 1967 |
| Headquarters | Yongin, South Korea |
| Official Website | Click Here |
GC Biopharma maintains a diverse portfolio of specialty medicines to address various metabolic conditions in South Korea.